immunosuppression reduction
Showing 1 - 25 of >10,000
Immunosuppression Reduction in Failed Allograft Guided by cfDNA
Recruiting
- Kidney Transplant; Complications
- +2 more
- Blood Draw
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 21, 2022
Kidney Transplant, BK Viremia Trial (Intravenous immunoglobulin)
Not yet recruiting
- BK Viremia
- +2 more
- Immunosuppression reduction/modification + intravenous immunoglobulin
- Immunosuppression reduction/modification
- (no location specified)
Oct 16, 2022
COVID-19 Trial in Vienna (Immunosuppression reduction, No immunosuppression reduction)
Active, not recruiting
- COVID-19
- Immunosuppression reduction
- No immunosuppression reduction
-
Vienna, AustriaMedical University of Vienna
Apr 16, 2022
Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,
Recruiting
- Kidney Transplant Recipients
- Liver Transplant Recipients
- Pfizer-BioNTech Bivalent COVID-19 Vaccine
- +3 more
-
San Diego, California
- +14 more
Oct 31, 2022
COVID-19, Immunosuppression, Vaccine Response Impaired Trial in Sacramento (Reduction in antimetabolite immunosuppression)
Recruiting
- COVID-19
- +2 more
- Reduction in antimetabolite immunosuppression
-
Sacramento, CaliforniaUniversity of California, Davis
Feb 7, 2022
COVID-19 Acute Respiratory Distress Syndrome, Immunosuppression Trial (The Pfizer mRNA-based BNT162b2 vaccine)
Not yet recruiting
- COVID-19 Acute Respiratory Distress Syndrome
- Immunosuppression
- The Pfizer mRNA-based BNT162b2 vaccine
- (no location specified)
Oct 5, 2021
Kidney Transplant Rejection, Immunosuppression Trial in Boston (Allosure, Immunosuppression reduction, Trugraf)
Active, not recruiting
- Kidney Transplant Rejection
- Immunosuppression
- Allosure
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 2, 2021
BK Virus Nephropathy After Kidney Transplantation Trial in France (everolimus)
Active, not recruiting
- BK Virus Nephropathy After Kidney Transplantation
-
Amiens, France
- +14 more
Aug 18, 2022
Kidney Transplant Recipient Trial in Phoenix, Jacksonville, Rochester (Janssen Ad26.CoV2.S Vaccine, Reduction in
Recruiting
- Kidney Transplant Recipient
- Janssen Ad26.CoV2.S Vaccine
- +2 more
-
Phoenix, Arizona
- +2 more
Jul 14, 2022
Renal Transplantation Trial in France (Systematic transplantectomy, Progressive reduction of immunosuppression)
Completed
- Renal Transplantation
- Systematic transplantectomy
- Progressive reduction of immunosuppression
-
Clermont-Ferrand Cedex, France
- +8 more
Nov 18, 2022
Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient) Trial in San Francisco, Chicago,
Completed
- Liver Transplant Recipient
- Living Donor (of the Respective Liver Transplant Recipient)
- darTregs
- +4 more
-
San Francisco, California
- +2 more
Jan 21, 2021
TruGraf Liver Gene Expression Serial Test
Not yet recruiting
- Autoimmune Liver Disease
- +3 more
- TruGraf®
- (no location specified)
Sep 27, 2023
Kidney Transplantation, BK Virus, Isoantibodies Trial in Boston (IVIg, Placebo)
Completed
- Kidney Transplantation
- +2 more
- IVIg
- Placebo
-
Boston, Massachusetts
- +1 more
Sep 2, 2021
Development of Antibodies Against Transplant Kidney After
Completed
- Acute Infection
- Kidney Failure
- Level of antibodies
-
Ostrava, Moravian-Silesian Region, CzechiaUniversity Hospital Ostrava
Sep 8, 2023
Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,
Completed
- Renal Insufficiency
- Kidney Transplantation
- tacrolimus OD, mycophenolic acid, prednisolone
-
Amsterdam, Netherlands
- +2 more
Dec 20, 2021
TRU-IMMUNO: Optimizing Liver Immunosuppression
Not yet recruiting
- Liver Transplant Rejection
- Patients monitored with TruGraf and TRAC Liver testing
- (no location specified)
Apr 26, 2022
Evaluation of the Impact of Reduced Immunosuppression
Enrolling by invitation
- Graft Vs Host Disease
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Renal Transplant Rejection, Renal Transplant Infection Trial (Tacrolimus)
Not yet recruiting
- Renal Transplant Rejection
- Renal Transplant Infection
- (no location specified)
Nov 1, 2022
IgA Nephropathy at High Risk of Developing ESRD Trial in Beijing (The Yi-Qi-Qing-Jie herbal compound, Immunosuppressants,
Recruiting
- IgA Nephropathy at High Risk of Developing ESRD
- The Yi-Qi-Qing-Jie herbal compound
- +3 more
-
Beijing, Beijing, ChinaGuang anmen Hospital, China Academy of Chinese Medical Sciences
Mar 15, 2022
Pharmacological Action Trial (Rituximab, Dexamethasone)
Not yet recruiting
- Pharmacological Action
- (no location specified)
Sep 22, 2022
Kidney Transplantation Trial in Germany (MIC, Standard of Care)
Recruiting
- Kidney Transplantation
- MIC
- Standard of Care
-
Frankfurt, Germany
- +4 more
Oct 11, 2022
Kidney Transplant Rejection, Immunosuppression Trial in San Francisco (TruGraf, Standard of Care)
Recruiting
- Kidney Transplant Rejection
- Immunosuppression
- TruGraf
- Standard of Care
-
San Francisco, CaliforniaCalifornia Pacific Medical Center
Aug 26, 2021
Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)
Not yet recruiting
- Immune Tolerance
- +2 more
- Tacrolimus or Cyclosporine A
-
Tianjin, Tianjin, ChinaTianjin First Central Hospital
Nov 23, 2023
Immunosuppression, Immune Tolerance Trial in Toronto (Controlled weaning of immunosuppression)
Completed
- Immunosuppression
- Immune Tolerance
- Controlled weaning of immunosuppression
-
Toronto, Ontario, CanadaToronto General Hospital
Sep 29, 2021
Inflammatory Disease, Disease Crohn, Bowel Disease Trial in Amsterdam (Infliximab subcutaneous, Immunosuppressive Agents)
Recruiting
- Inflammatory Disease
- +2 more
- Infliximab subcutaneous
- Immunosuppressive Agents
-
Amsterdam, North Holland, NetherlandsAmsterdam UMC AMC
Sep 27, 2023